Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2025 Earnings Call Transcript May 1, 2025
Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.89002.
Operator: Good morning ladies and gentlemen and welcome to the Alnylam Pharmaceuticals Q1 2025 Earnings Conference Call. At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] This call is being...
